Company / Profit Margin
Arcturus Therapeutics Holdings Inc. Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-80.2%
FY2025
5-year range
-1648.0% / -17.8%
FY2021-FY2025
Trend
-50.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -17.8% to -80.2% over the past 2 years.
Based on SEC 10-K filings.
-80.2% in FY2025 with a 5-year CAGR of +58.1%.
Declined from -17.8% to -80.2% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +1567.8pp
- 5-Year Change
- +58.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 50.9% year-over-year.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -80.2% | -50.9% |
| FY2024 | -53.1% | -198.2% |
| FY2023 | -17.8% | +98.9% |
| FY2022 | -1648.0% | +0.0% |
| FY2021 | -1648.0% | -1091.7% |
| FY2020 | -138.3% | +0.0% |
| FY2019 | -138.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026